Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel M Verbeek

Showing results (151-160 of 237) with videos related to

Pageof 24
Sort By:
Journal of Neuroinflammation|December 6, 2017
Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MSIlona B Bruinsma, Marie van Dijk, Claire Bridel, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Alzheimer'S Research & Therapy|March 17, 2018
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translationCharlotte E Teunissen, Markus Otto, Sebastiaan Engelborghs, et al.
European Journal of Human Genetics : EJHG|April 6, 2017
Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndromeMichèl A Willemsen, Lisenka Elm Vissers, Marcel M Verbeek, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot StudyH Bea Kuiperij, Alexandra A M Versleijen, Marijke Beenes, et al.
Journal of Alzheimer'S Disease : JAD|June 25, 2023
Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2Natalia Ortí-Casañ, Harald Wajant, H Bea Kuiperij, et al.
Annals of Neurology|August 19, 2007
Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase geneMarcel M Verbeek, Gerry C H Steenbergen-Spanjers, Michèl A A P Willemsen, et al.
Acta Neuropathologica Communications|January 8, 2024
Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patientsMarc Vervuurt, Joseph M Schrader, Anna M de Kort, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 29, 2020
CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSDIris Kleerekooper, Megan K Herbert, H Bea Kuiperij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 7, 2021
Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's diseaseAnna M De Kort, H Bea Kuiperij, Iris Kersten, et al.
Pageof 24

Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Journal of Neuroinflammation|December 6, 2017
Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MSIlona B Bruinsma, Marie van Dijk, Claire Bridel, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Alzheimer'S Research & Therapy|March 17, 2018
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translationCharlotte E Teunissen, Markus Otto, Sebastiaan Engelborghs, et al.
European Journal of Human Genetics : EJHG|April 6, 2017
Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndromeMichèl A Willemsen, Lisenka Elm Vissers, Marcel M Verbeek, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot StudyH Bea Kuiperij, Alexandra A M Versleijen, Marijke Beenes, et al.
Journal of Alzheimer'S Disease : JAD|June 25, 2023
Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2Natalia Ortí-Casañ, Harald Wajant, H Bea Kuiperij, et al.
Annals of Neurology|August 19, 2007
Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase geneMarcel M Verbeek, Gerry C H Steenbergen-Spanjers, Michèl A A P Willemsen, et al.
Acta Neuropathologica Communications|January 8, 2024
Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patientsMarc Vervuurt, Joseph M Schrader, Anna M de Kort, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 29, 2020
CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSDIris Kleerekooper, Megan K Herbert, H Bea Kuiperij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 7, 2021
Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's diseaseAnna M De Kort, H Bea Kuiperij, Iris Kersten, et al.
Pageof 24